Skip to content

Author

Abigail F. Quesnelle

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

NU7441 reveals DNA-PK and BRD4 convergence as a therapeutic vulnerability in ovarian cancer

Evidence is provided that NU7441, traditionally classified as a selective DNA-PK inhibitor, also functions as a BRD4 inhibitor by directly displacing BRD4 from acetylated chromatin and it is suggested that multi-target inhibition of BRD4 and DNA-PK can be leveraged to support new therapeutic strategies.

Julie A. Disharoon, Brandon C. Johnson, Elizabeth A. Ampolini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.